期刊文献+

神经外科重症监护病房肺部感染173例临床分析 被引量:9

Analysis of 173 cases of pulmonary infection in NICU
原文传递
导出
摘要 目的探讨神经外科重症监护病房(NICU)肺部感染的易感因素、病原体的构成及药敏情况,指导临床有效预防及合理治疗。方法回顾性分析2010年1月至2011年9月NICU肺部感染痰培养检出的致病菌株及其耐药性、易感因素。结果其分离出细菌602株。其中G-菌363株(60.2%);G+菌71株(11.8%);霉菌168株(28.0%)。G-菌中以不动杆菌、铜绿假单胞菌为主。G+菌以表皮葡萄球菌为主。结论不动杆菌已成为NICU内肺部感染的优势菌群,对临床常用抗生素有多重耐药现象。尽快进行痰液细菌学检查以明确病原菌,根据药敏结果有针对性地选用抗生素是控制危重患者肺部感染的有效措施。 Objective To explore the risk factors, composition of pathogen and drug sensitivity of pulmonary infection in neurosurgical intensive care unit(NICU) and provide basis forclinical effective prevention and appropriate treatment. Methods Retrospective analysis the detected pathogenic strains, theirdrug resistance and predisposing factors of the cases of pulmonary infection in NICU from January 2010 to September 2011. Results Among the isolated 602 bacteriastrains,363 strains(60. 2% )were G- bacteria,71 strains( 11.8 % ) were G + bacteria, 168 strains ( 28 % ) were molds. In G - bacteria, the main strains are acinetobacter and pseudomonas aeruginosa, and in G+ bacteria, staphylococcus epidermidis based most. Conclusion Acinetobacter has become the dominant flora of pulmonary infection in NICU and it has muhidrug resistance to antibiotics in clinical. The Specific pathogen should be indentified through bacteriological examination of sputum as soon as possible, and the antibiotics should be used alternatively based on their drug sensitivity to control lung infection in critically ill patients.
出处 《中国综合临床》 2012年第12期1296-1299,共4页 Clinical Medicine of China
关键词 神经外科 重症监护治疗病房 肺部感染 Neurosurgery Neurosurgery intensive care unit Lung infection
  • 相关文献

参考文献10

二级参考文献39

共引文献126

同被引文献52

  • 1吴宏姣.全面护理干预对降低神经外科重症患者医院感染率的效果[J].环球中医药,2013,6(S2):217-217. 被引量:2
  • 2李华茵,何礼贤,胡必杰,王葆青,陈雪华,马伟.呼吸机相关肺炎内源性感染途径的分子流行病学研究[J].中华医院感染学杂志,2004,14(2):121-125. 被引量:153
  • 3Verwaest C, Belgian Multicenter Study Group. Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit [J]. Clin Microbiol hffect, 2000,6(6) :294-302.
  • 4Drusano GL, Lode H, Edwards JR Meropenem : clinical response in relation to in vitro susceptibility [J]. Clin Microbiol Infect, 2000,6(4) :185-194.
  • 5Soo Hoo GW, Wen YE, Nguyen TV, et al. Impact of clinical guidelines in the management of severe hospital-acquired' pneumonia [ J]. Chest ,2005,128 (4) :2778-2787.
  • 6许伟.神经外科重症监护患者并发肺部感染的相关因素护理[J],健康必读(下旬刊),2012,125(3):129-130.
  • 7Gao W,Mao Q,Feng AW. Inhibition of pre-B cell colo ny-enhancing factor attenuates inflammation and apoptosis in duced by pandemic H1 N1 2009 in lung endothelium[J].{H}Respiratory Physiology & Neurobiology,2011,(2):235-241.
  • 8de Miguel-Diez J,Carrasco Garrido P,Hernández-Barrera V. Hospitalizations from pandemic influenza (pH1 N1) infections among patients with asthma or COPD in Spain[J].{H}Journal of Infection,2012,(1):95-98.
  • 9丽冰.优质护理在预防神经外科重症病人肺部感染的效果观察[J].中国保健营养(下旬刊),2014,24:2147-2148.
  • 10马新燕,徐雪荣.3种方案治疗小儿肺炎成本-效果分析[J].中国医院用药评价与分析,2008,8(3):214-215. 被引量:7

引证文献9

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部